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Summary.-Experiments have been carried out to determine whether the growth
delay induced in small EMT6 spheroids (-250 ,um in diameter) by a range of cyto-
toxic drugs can be increased by pre-incubation of the spheroids under hypoxic
conditions with misonidazole (MISO). Hypoxic pre-incubation was for 3 or 5 h in
the presence of 5 mm MISO, and caused a growth delay of about 1 day or 2 days
respectively.
Sensitization to nitrogen mustard (HN2), melphalan, chlorambucil, BCNU and
CCNU was seen, but the shapes of the dose-response curves and the ratio of effects
for 3 h and 5 h pretreatment varied between the drugs. In contrast to the other
agents, hypoxic pre-incubation with MISO reduced the spheroid response to
adriamycin.
THE 2-NITROIMIDAZOLE, misonidazole
(MISO), in addition to its action as a
radiosensitizer of hypoxic cells, may also
sensitize cells to heat and to a number of
cytotoxic drugs (Stratford et al., 1980).
This sensitization occurs when cells are
exposed to MISO under hypoxic (but not
oxic) conditions for a period of hours
before exposure to the second modality.
Much recent interest has centred on the
question of whether or not this in vitro
"preincubation" phenomenon underlies
the in vivo sensitization of tumours to
chemotherapy by MISO (Rose et al., 1980;
Clement et al., 1980).
In this paper, experiments are des-
cribed in which an in vitro tumour model
(i.e. multicellular spheroids of the EMT6
mouse tumour) has been used to assess the
effect of hypoxic pre-incubation with
MISO upon the growth delay induced by a
range of cytotoxic drugs. In this system,
the cells are grown, pre-incubated, drug-
treated and assayed as intact 3-dimen-
sional aggregates, and therefore form an
intermediate model system between single
calls treated in vitro and assayed by
clonogenic survival, and in vivo tumours
assayed by growth delay.
MATERIALS AND METHODS
The system used in this laboratory for the
induction and growth ofEMT6 mouse tumour
spheroids to a size of around 250 ,um in
diameterhasrecentlybeendescribed (Twenty-
man, 1980a). Upon reaching this size (usually
on Day 6 after induction), 5-10 x 103 spher-
oids were transferred to 100ml spinner cul-
ture vessels (Belco) containing 100 ml of
complete Eagle's medium with 20% newborn
calf serum (Gibco Biocult) at 37°C. MISO
was added to the medium to give a final con-
centration of 5 mm, and N2 with 5% CO2
(< 10 pt/106 02; British Oxygen Co.) was
passed into the spinner vessel at a rate of
750-1000 ml/min. No measurements were
made of02 tension in the medium, but RIF-1
mouse tumour cells exposed to identical
conditions and X-irradiated were found to
give a hypoxic response (OER >2.5) after 1 h
of gassing. After the appropriate exposure in
the spinners, spheroids were rinsed twice with
fresh medium and exposed to graded con-
centrations of cytotoxic drug (see Table I) for
1 h in glass tubes with intermittent agitation.P. R. TWENTYMAN
TABLE I.-Cytotoxic drugs studied
Drug
Melphalan
(MEL)
Nitrogen mustard
(HN2)
1,3 bis(2-chloroethyl)-1-nitrosourea
(BCNU)
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea
(CCNU)
Chlorambucil
(CHL)
Adriamycin
(ADM)
Source
Chester Beatty Research
Institute
Boots Pure Drug Co.,
Nottingham, England
U.S. National Cancer
Institute
U.S. National Cancer
Institute
Chester Beatty Research
Institute
Pharmitalia Ltd., Italy
Diluent
Acidified ethanol
PBS
Absolute ethanol
Absolute ethanol
Acidified ethanol
PBS
After initial dilution of the drugs, a volume of 0-03-0-2 ml was added to 10 ml of medium to give the
required final concentration.
Control groups in various experiments con-
sisted of spheroids exposed to MISO under
oxic conditions, hypoxia alone, or oxic
conditions alone for the appropriate time.
After drug exposure, spheroids were again
rinsed twice and then single spheroids were
transferred with a Pasteur pipette to indi-
vidual wells on 96-well plastic multidishes
(Sterilin Limited).
Each well had been base-coated with 0-1 ml
complete medium containing 0.75% Noble
agar (Difco) to prevent adhesion of the
spheroid to the plastic surface. Complete
medium (0.2 ml) was then added to each well.
These wells are considerably smaller than
those we have previously used (Twentyman,
1980a) but comparative studies have shown
that spheroid growth up to a diameter of
600-700 ,um is identical in both types.
Spheroids were then measured using an
Olympus inverted microscope with a tele-
vision monitor inserted into the third eye-
piece. The output from the camera was pro-
cessed by an Optomax image-analysis system
(Micromeasurements, Saffron Walden) which
measured the cross-sectional area of each
spheroid. The data from the analysis were
fed directly to a Commodore "Pet" micro-
computer which calculated the mean dia-
meter of the 12 spheroids in each treatment
group. The wells were then incubated at
37°C in an atmosphere of 8% CO2+92% air.
Subsequent measurements of spheroid dia-
meter were made 3 times weekly and the
medium was changed at each measurement
for wells containing spheroids >,400 um in
diameter.
RESULTS
Misonidazole alone
In 19 separate experiments the mean
growth delay after 3 h hypoxic incubation
with 5 mm MISO was 1-30 + 0-30 days
(2 x s.e.). After 5 h hypoxic incubation
the value was 2-18 + 0-80 days (10 separate
experiments). In an experiment to com-
pare growth delay with cell survival
measured immediately after hypoxic incu-
bation with MISO, a growth delay of 1 day
was found to correspond to a cell surviving
fraction of 0 3-0'5, whilst 2 days corres-
ponded to a surviving fraction of 0-1-0*2.
Hypoxia alone or 5 mm MISO under oxic
conditions did not significantly delay the
growth ofspheroids.
Cytotoxic-drug sensitivity after 3h or 5h
incubation with MISO under hypoxia
A typical set of regrowth curves for
small EMT6 spheroids after treatment
with various doses of MEL is shown in
Fig. 1. Similar regrowth curves were
plotted for each experiment. From such
curves the time for each treatment group
to increase its mean diameter by 200 ,um
was read off and plotted as growth delay
vs drug dose, as shown in Fig. 2. From
these plots, values have been interpolated
for the dose of cytotoxic drug to give
growth delays of 2 and 5 days. For pre-
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curves similar to those shown in Fig. 1.
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for spheroi(ls to increase their mean
(liameter by 200 ,um.
treated spheroids (i.e. MISO under hypoxic
conditions) these growth delays of 2 and
5 days were additional to the growth
delay due to pretreatment alone.
As an example of this procedure, see
Fig. 2. In this particular experiment
(Expt A for MEL in Table II) the growth
delay in spheroids receiving 3h hypoxic
pretreatment alone was 0-6 days. Pre-
treated spheroids exposed to 1, 2, 3, 4.5
and 6 jug/ml of MEL showed growth
delays of 2.2, 1 8, 2 8, 4 0 and 5-8 days
respectively, which have therefore been
corrected to 16. 1P2, 22, 3-4 and 5-2 days
respectively on the graph. Values of the
MELdoses togive a growth delay of5 days
can therefore be read off as 117 jtg/ml (no
pretreatment) and 6-2 Htg/ml (3h pre-
treatment) to give a DMF of 1.9. An
identical analysis was followed for all the
experimental data shown in Tables II and
III.
The changes in drug sensitivity brought
about by 3h pretreatment in the various
experiments are shown in Table II. In
Expt C for MEL, where DMFs of 1-8 and
1-4 were obtained for hypoxic MISO pre-
treatment, the effect of pretreating with
either 5mM MISO under oxic conditions or
hypoxia alone (i.e. no MISO) was also
studied. Neither of these pretreatments
caused any significant change in response
to MEL. It may be seen that, in general,
pretreated spheroids were more sensitive to
subsequent cytotoxic drug treatment than
were control spheroids. In most experi-
ments, DMF lay between 1 and 2, though
one experiment with HN2 produced
DMFs below 1. The highest DMFs were
found in experiments with MEL and CHL.
To see whether the DMFs could be
increased by a longer period of hypoxic
pre-incubation with MISO, some experi-
ments also used 5h pre-incubation. The
results are shown in Table III. For MEL,
the DMF for 5 h (3.6) was larger than in
the same experiment for 3h pretreatment
(2.0) and for HN2 the values for 5 h were
higher than in either of the 3h determina-
tions. For the other agents, however, the
DMFs were similar at 3 and 5 h.
The data for ADM cannot be presented
in the same form as those for the other
agents, because of the relatively short
growth delays. In Table IV, growth delays
for an ADM dose of 10 [kg/ml are com-
pared for control and pretreated spheroids.
It may be seen that in each of the 3
experiments there was less growth delay
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567TABLE II.-Spheroid growth delay caused by cytotoxic drugs: Effect of 3h pre-incubation
with 5mM MISO under hypoxic conditions
Drug Expt
MEL A
B
c
D
HN2 A
B
BCNU A
B
CCNU A
B
CHL A
B
Growth
delay
(days)
2
5
2
2
5
5
2
5
2
5
Dose of drug required
(.g/ml)
Control MISO DMF*
5*4 2-4 2-3
11-7 6-2 1-9
6-2 3-1 2-0
3-5 2-0 1-8
5*7 4-1 1-4
10-5 2-5 4-2
0-56 0-46 1-2
1-17 1-13 1-0
0-16 0-22 0-7
0 50 0-37 0-9
2 2-9
5 5 9
2 2-1
5 5-2
2 8-6
5 13-5
2 3-8
5 8-6
2 14-0
5 28-0
2 7 5
5 18-8
2-4
3-6
2-2
4-1
7-1
10-5
3-0
8-0
9-2
18-5
5-6
11-5
* DMF =Dose-modifying factor.
TABLE III.-Spheroid growth delay caused by cytotoxic drugs: Effect of 5h pre-incubation
with 5mM MISO under hypoxic conditions
Dose of drug required
Growth (.Kg/ml)
delay A
Drug
MEL
HN2
Expt
B*
X
BCNU X
CCNU X
y
CHL
(days)
2
2
5
2
5
Control
6-2
0-25
0-66
3-7
5-0
2 3-5
5 7-4
2 3-0
5 5-0
2 7-5
5 18-8
MISO DMF
1-7
0-16
0-40
3-2
4-4
2-1
5-2
2-6
4-6
5-0
14-0
3-6
1-6
1-7
1 -2
1-1
1-7
1 -4
1-1
1-2
1*5
1-3
* Part of large experiments included in Table II, thus allowing direct comparison of DMFs at 3h and 5h
pre-incubation.
in spheroids pretreated with hypoxic
MISO. Where pre-incubation was with
hypoxia alone, however, there was no
reduction in ADM sensitivity.
DISCUSSION
These data essentially confirm the pre-
liminary report of Stratford et al. (1980)
that pre-incubation with MISO under
hypoxic conditions is able to sensitize
cells to a range of cytotoxic drugs. Five
of the 6 agents studied (HN2, MEL,
BCNU, CCNU and CHL) gave DMFs
mostly between 1I1 and 2-0. The values for
HN2 at 3 h, however, average close to 1
though larger DMFs were obtained for 5h
pre-incubation. The values for MEL
1-2
1 -6
1-0
1-3
1-2
1-3
1-3
1-1
1-5
1-5
1-3
1-6
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TABLE IV.-Spheroid growth delay caused by 10 ,ug/ml Adriamycin: Effect of 3h pre-
incubation wvith 5mM MISO under hypoxic conditions
Growth delay (days)
A -
Control (I) ADM (II) (II)H(I)
0.0 2-0 2-0
1.0 1-6 0-6
0o0
0 2
0o0
0 9
-0-2
tended to be higher than those for the
other agents, averaging around 2-0 for
3h pre-incubation. These values may be
compared with DMFs around 3, 2 and 1.5
for HN2, MEL and cis-platinum reported
by Stratford et al. (1980). In their study,
the pre-incubation of 2h hypoxia with
5mM MISO reduced the cell survival to
between 25% and 60% of control, which
is similar to the effect of the pre-incuba-
tion conditions in the current series of
experiments.
In our earlier study of interaction
between the cytotoxicities of MISO and
conventional drugs in large EMT6 spher-
oids pretreated under oxic conditions
(Twentyman, 1980b) we found no change
in response to ADM or BCNU, and a
reduction in sensitivity to HN2 of cells
surviving MISO cytotoxicity. In those
experiments, however, the pre-incubation
time was 21 h, and it seems likely that
exposure for prolonged periods to 5mM
MISO brings about kinetic changes in
surviving cells which might reduce
their response to proliferation-dependent
chemotherapy (Lindmo et al., 1979). The
present results, therefore, are not incom-
patible with our previous results under
different pre-incubation conditions.
Examination of the data shows that in
some experiments, the DMF for 2 days'
growth delay is greater than that for 5
days' growth delay, whereas in other
experiments the reverse is found. This
would indicate that the effect is not simply
a loss of shoulder from the dose-response
curves, as is the dominant effect for
38
3-7
2 *5
2-1
1*6
2 -5
3-7
2 3
2 1
0 7
2-7
ionizing radiation (Wong et al., 1978;
Stratford et al., 1980).
Our finding that sensitivity to ADM is
reduced after hypoxic preincubation with
MISO conflicts with the finding by
Tannock (1980) of tumour sensitization in
vivo to ADM by MISO. However, no
such sensitivity was found by Rose et al.
(1980) or by Dr N. J. McNally (personal
communication).
Tumour sensitization by MISO to
alkylating agents and nitrosoureas is,
however, fairly general among published
investigations (Rose et at., 1980; Clement
et al., 1980; plus about 8 other more
recent papers). In most in vivo studies,
MISO has been administered less than 1 h
before the cytotoxic drug. There is there-
fore no prolonged pretreatment. On the
other hand it has recently been shown
(Workman & Twentyman, 1982; Dr J. M.
Brown, personal communication), that
repeated administration of MISO to mice
produces greater tumour sensitization
than a large single dose. This suggests that
the in vitro pretreatment effects described
by Stratford et al. (1980) and in this study
might be related to the observed in vivo
tumour senitization by MISO. The mech-
anism by which the in vitro pretreatment
effect operates is still far from clear, but
the demonstration that MISO under
hypoxic conditions reduces the levels of
intracellular glutathione (Varnes et al.,
1980) offers an attractive possibility.
I thank Miss Daryl Knight and Mrs Karen Wright
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was kindly sulpplied by Dr C. Smithen of Roche
Expt Pretreatment
A
B
c
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